You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AMIFOSTINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amifostine patents expire, and when can generic versions of Amifostine launch?

Amifostine is a drug marketed by Eugia Pharma Speclts and Sun Pharm and is included in two NDAs.

The generic ingredient in AMIFOSTINE is amifostine. There are six drug master file entries for this compound. Additional details are available on the amifostine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMIFOSTINE?
  • What are the global sales for AMIFOSTINE?
  • What is Average Wholesale Price for AMIFOSTINE?
Drug patent expirations by year for AMIFOSTINE
Drug Prices for AMIFOSTINE

See drug prices for AMIFOSTINE

Recent Clinical Trials for AMIFOSTINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institut du Cancer de Montpellier - Val d'AurellePhase 3
Tata Memorial CentrePhase 3
British Columbia Cancer AgencyPhase 2/Phase 3

See all AMIFOSTINE clinical trials

Medical Subject Heading (MeSH) Categories for AMIFOSTINE
Paragraph IV (Patent) Challenges for AMIFOSTINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ETHYOL For Injection amifostine 500 mg/vial 020221 1 2004-04-16

US Patents and Regulatory Information for AMIFOSTINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma Speclts AMIFOSTINE amifostine INJECTABLE;INJECTION 204363-001 Jul 17, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm AMIFOSTINE amifostine INJECTABLE;INJECTION 077126-001 Mar 14, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.